Literature DB >> 15278722

Impact of holmium:YAG and neodymium:YAG lasers on the efficacy of DNA delivery in transitional cell carcinoma.

Thomas Knoll1, Lutz Trojan, Sigrun Langbein, Sreedhar Sagi, Peter Alken, Maurice Stephan Michel.   

Abstract

New approaches in the treatment of transitional cell carcinoma (TCC) are using gene therapy to influence the disease at the genetic level. Technical advances in genomics, the availability of tissue-specific gene promoters and other developments have made this approach more realistic. Transporting the gene into the target cell is still the major problem. Several transfection techniques have been introduced. Transfection of naked DNA is one of the simplest to perform but transfection rates have been very poor. We investigated the influence of laser energy on transfection efficacy in urothelial cancer cells in vitro with two types of medical lasers. A suspension of human transitional cancer cells (UM-UC3; 3.5 million cells/ml) was mixed with 200 microg of plasmid DNA (pEGFP-N1). Two types of laser energy, neodymium:YAG (Nd:YAG) and holmium:YAG (Ho:YAG), were applied to the cell suspension in different energy settings. Twenty four hours after treatment, transfection rates were measured with FACS analysis. Energy setting parameters that determine the efficacy of laser were investigated. The significance of different transfection rates was estimated with the student's t-test. We demonstrated that the Nd:YAG laser was not suitable for achieving significant transfection of the reporter gene to the cells. In contrast, the Ho:YAG laser produced satisfactory transfection rates. There was an increase in transfection with increasing frequency of laser pulses, from 16% with 2 Hz up to 40% with 10 Hz (p < 0.0005). Pulse frequency was therefore stabilised at 10 Hz. Pulse energy (mJ) showed the same dependency: a transfection rate of 18.3% was achieved with 1,000 mJ and 53.8% with 2,000 mJ (p > 0.0005). Additionally, we investigated the impact of total pulse number (imp) with different pulse energies. At 1,000 mJ, a transfection rate of 18.3% was estimated with 200 imp and 48.56% with 750 imp, (p < 0.0005). At 2,000 mJ, a transfection rate of 53.8% was achieved with 200 imp and 58.26% with 500 imp. The optimal laser setting observed in this experiment was 10 Hz, 2,000 mJ and 500 imp. This study indicates that the efficacy of naked DNA delivery into TCC in vitro is improvable by application of Ho:YAG laser energy. The Nd:YAG laser did not increase transfection rates in our model. Our results with the Ho:YAG laser are encouraging for further studies to optimise DNA delivery. As TCC tissue is relatively easy to access, this method could become an effective and minimally invasive procedure in urothelial cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15278722     DOI: 10.1007/s10103-004-0299-5

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  10 in total

1.  New technique for gene transfection using laser irradiation.

Authors:  Y Shirahata; N Ohkohchi; H Itagak; S Satomi
Journal:  J Investig Med       Date:  2001-03       Impact factor: 2.895

2.  Targeted transfection by femtosecond laser.

Authors:  Uday K Tirlapur; Karsten König
Journal:  Nature       Date:  2002-07-18       Impact factor: 49.962

3.  NATURAL HISTORY AND CLINICAL BEHAVIOR OF IN SITU CARCINOMA OF THE HUMAN URINARY BLADDER.

Authors:  M R MELAMED; N G VOUTSA; H GRABSTALD
Journal:  Cancer       Date:  1964-12       Impact factor: 6.860

4.  Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo.

Authors:  C Bass; G Cabrera; A Elgavish; B Robert; G P Siegal; S C Anderson; D C Maneval; D T Curiel
Journal:  Cancer Gene Ther       Date:  1995-06       Impact factor: 5.987

5.  Green fluorescent protein as a marker for gene expression.

Authors:  M Chalfie; Y Tu; G Euskirchen; W W Ward; D C Prasher
Journal:  Science       Date:  1994-02-11       Impact factor: 47.728

6.  Aequorea green fluorescent protein. Expression of the gene and fluorescence characteristics of the recombinant protein.

Authors:  S Inouye; F I Tsuji
Journal:  FEBS Lett       Date:  1994-03-21       Impact factor: 4.124

7.  Phase i study of intravesical vaccinia virus as a vector for gene therapy of bladder cancer.

Authors:  L G Gomella; M J Mastrangelo; P A McCue; J R Maguire HC; S G Mulholland; E C Lattime
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

8.  Genetic alterations in primary bladder cancers and their metastases.

Authors:  R M Hovey; L Chu; M Balazs; S DeVries; D Moore; G Sauter; P R Carroll; F M Waldman
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

9.  Allelotype of human bladder cancer.

Authors:  M A Knowles; P A Elder; M Williamson; J P Cairns; M E Shaw; M G Law
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

10.  Heterogeneity of erbB-2 gene amplification in bladder cancer.

Authors:  G Sauter; H Moch; D Moore; P Carroll; R Kerschmann; K Chew; M J Mihatsch; F Gudat; F Waldman
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

  10 in total
  3 in total

Review 1.  Single cell optical transfection.

Authors:  David J Stevenson; Frank J Gunn-Moore; Paul Campbell; Kishan Dholakia
Journal:  J R Soc Interface       Date:  2010-01-11       Impact factor: 4.118

2.  In vitro and ex vivo gene delivery into proximal tubular cells by means of laser energy--a potential approach for curing cystinuria?

Authors:  Thomas Knoll; Sreedhar Sagi; Lutz Trojan; Axel Schaaf; Peter Alken; Maurice Stephan Michel
Journal:  Urol Res       Date:  2004-01-13

3.  Optical injection of mammalian cells using a microfluidic platform.

Authors:  Robert F Marchington; Yoshihiko Arita; Xanthi Tsampoula; Frank J Gunn-Moore; Kishan Dholakia
Journal:  Biomed Opt Express       Date:  2010-08-09       Impact factor: 3.732

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.